Regimen of Coronavirus Disease 2019 Vaccination Influences Extent and Kinetics of Antibody Avidity.
J Infect Dis
; 226(11): 1909-1912, 2022 11 28.
Article
em En
| MEDLINE
| ID: mdl-36111560
ABSTRACT
We investigated antibody titers and avidity after heterologous versus homologous coronavirus disease 2019 vaccination over 6 months after the second dose. We found a significantly higher avidity in regimens including at least 1 dose of the adenoviral vector vaccine ChAdOx1-S compared with 2 doses of the mRNA vaccine BNT162b2.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
COVID-19
/
Vacina BNT162
/
ChAdOx1 nCoV-19
/
Afinidade de Anticorpos
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article